vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Zeo Energy Corp. (ZEO). Click either name above to swap in a different company.

Ceribell, Inc. is the larger business by last-quarter revenue ($24.8M vs $18.6M, roughly 1.3× Zeo Energy Corp.). Zeo Energy Corp. runs the higher net margin — -10.8% vs -54.6%, a 43.8% gap on every dollar of revenue. Zeo Energy Corp. produced more free cash flow last quarter ($2.3M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

CBLL vs ZEO — Head-to-Head

Bigger by revenue
CBLL
CBLL
1.3× larger
CBLL
$24.8M
$18.6M
ZEO
Higher net margin
ZEO
ZEO
43.8% more per $
ZEO
-10.8%
-54.6%
CBLL
More free cash flow
ZEO
ZEO
$13.2M more FCF
ZEO
$2.3M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBLL
CBLL
ZEO
ZEO
Revenue
$24.8M
$18.6M
Net Profit
$-13.5M
$-2.0M
Gross Margin
87.3%
Operating Margin
-58.9%
-11.8%
Net Margin
-54.6%
-10.8%
Revenue YoY
-0.4%
Net Profit YoY
-360.9%
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
ZEO
ZEO
Q4 25
$24.8M
$18.6M
Q3 25
$22.6M
$23.9M
Q2 25
$21.2M
$18.1M
Q1 25
$20.5M
$8.8M
Q4 24
$18.6M
Q3 24
$17.2M
$19.7M
Q2 24
$14.8M
Q1 24
$20.1M
Net Profit
CBLL
CBLL
ZEO
ZEO
Q4 25
$-13.5M
$-2.0M
Q3 25
$-13.5M
$-3.2M
Q2 25
$-13.6M
$-2.4M
Q1 25
$-12.8M
$-6.4M
Q4 24
$-435.3K
Q3 24
$-10.4M
$-424.3K
Q2 24
$-277.8K
Q1 24
$-1.5M
Gross Margin
CBLL
CBLL
ZEO
ZEO
Q4 25
87.3%
Q3 25
88.3%
57.9%
Q2 25
88.1%
59.8%
Q1 25
87.9%
99.3%
Q4 24
Q3 24
87.3%
50.2%
Q2 24
52.3%
Q1 24
Operating Margin
CBLL
CBLL
ZEO
ZEO
Q4 25
-58.9%
-11.8%
Q3 25
-64.8%
-8.3%
Q2 25
-70.5%
-15.8%
Q1 25
-69.3%
-153.8%
Q4 24
-6.0%
Q3 24
-57.8%
-15.2%
Q2 24
-18.0%
Q1 24
-20.1%
Net Margin
CBLL
CBLL
ZEO
ZEO
Q4 25
-54.6%
-10.8%
Q3 25
-59.6%
-13.5%
Q2 25
-64.4%
-13.3%
Q1 25
-62.4%
-72.4%
Q4 24
-2.3%
Q3 24
-60.6%
-2.2%
Q2 24
-1.9%
Q1 24
-7.6%
EPS (diluted)
CBLL
CBLL
ZEO
ZEO
Q4 25
$-0.35
Q3 25
$-0.37
Q2 25
$-0.38
Q1 25
$-0.36
$-0.48
Q4 24
$1.11
Q3 24
$-1.85
$-0.08
Q2 24
$0.03
Q1 24
$-1.54

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
ZEO
ZEO
Cash + ST InvestmentsLiquidity on hand
$159.3M
$6.1M
Total DebtLower is stronger
$79.1K
Stockholders' EquityBook value
$155.3M
$5.3M
Total Assets
$195.8M
$56.9M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
ZEO
ZEO
Q4 25
$159.3M
$6.1M
Q3 25
$168.5M
$3.9M
Q2 25
$177.4M
$68.7K
Q1 25
$182.7M
$2.9M
Q4 24
$5.6M
Q3 24
$14.1M
$4.3M
Q2 24
$5.3M
Q1 24
Total Debt
CBLL
CBLL
ZEO
ZEO
Q4 25
$79.1K
Q3 25
$84.6K
Q2 25
$642.8K
Q1 25
$715.4K
Q4 24
$787.7K
Q3 24
$858.6K
Q2 24
$1.6M
Q1 24
$748.8K
Stockholders' Equity
CBLL
CBLL
ZEO
ZEO
Q4 25
$155.3M
$5.3M
Q3 25
$164.1M
$-1.7M
Q2 25
$172.2M
$-59.4M
Q1 25
$180.9M
$-23.1M
Q4 24
$-88.9M
Q3 24
$-136.0M
$-39.3M
Q2 24
$-53.0M
Q1 24
$-173.0M
Total Assets
CBLL
CBLL
ZEO
ZEO
Q4 25
$195.8M
$56.9M
Q3 25
$199.5M
$58.5M
Q2 25
$207.7M
$46.2M
Q1 25
$213.5M
$47.4M
Q4 24
$61.0M
Q3 24
$47.1M
$47.1M
Q2 24
$49.1M
Q1 24
$50.1M
Debt / Equity
CBLL
CBLL
ZEO
ZEO
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
ZEO
ZEO
Operating Cash FlowLast quarter
$-10.8M
$2.4M
Free Cash FlowOCF − Capex
$-11.0M
$2.3M
FCF MarginFCF / Revenue
-44.2%
12.2%
Capex IntensityCapex / Revenue
0.7%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M
$-9.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
ZEO
ZEO
Q4 25
$-10.8M
$2.4M
Q3 25
$-11.1M
$-6.6M
Q2 25
$-7.5M
$-2.3M
Q1 25
$-11.4M
$-2.3M
Q4 24
$3.5M
Q3 24
$162.2K
Q2 24
$-2.2M
Q1 24
$-10.2M
Free Cash Flow
CBLL
CBLL
ZEO
ZEO
Q4 25
$-11.0M
$2.3M
Q3 25
$-11.5M
$-6.8M
Q2 25
$-7.6M
$-2.7M
Q1 25
$-11.6M
$-2.6M
Q4 24
$3.4M
Q3 24
$116.5K
Q2 24
$-2.3M
Q1 24
$-10.4M
FCF Margin
CBLL
CBLL
ZEO
ZEO
Q4 25
-44.2%
12.2%
Q3 25
-50.8%
-28.6%
Q2 25
-35.9%
-15.0%
Q1 25
-56.4%
-30.0%
Q4 24
18.2%
Q3 24
0.6%
Q2 24
-15.6%
Q1 24
-51.5%
Capex Intensity
CBLL
CBLL
ZEO
ZEO
Q4 25
0.7%
0.9%
Q3 25
1.6%
1.0%
Q2 25
0.3%
2.4%
Q1 25
0.7%
4.2%
Q4 24
0.5%
Q3 24
0.2%
Q2 24
0.7%
Q1 24
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

ZEO
ZEO

Nonrelated Party$18.1M98%
Related Party$432.1K2%

Related Comparisons